Edwards Lifesciences Buy or Sell Recommendation

Macroaxis provides Edwards Lifesciences Corporation buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Edwards Lifesciences positions. The advice algorithm takes into account all of Edwards Lifesciences Corporation available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Edwards Lifesciences buy-and-hold prospective. Additionally see Edwards Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
Edwards Lifesciences Corporation -- USA Stock  

USD 115.57  2.61  2.21%

Allowing for the 30-days total investment horizon, and your above average risk tolerance our recommendation regarding Edwards Lifesciences Corporation is 'Strong Buy'.
For the selected time horizon Edwards Lifesciences Corporation has a risk adjusted performance of 0.1699, jensen alpha of 0.2212, total risk alpha of (0.11), sortino ratio of 0.2298 and treynor ratio of 0.3599
Macroaxis provides buy, hold, or sell suggestion on Edwards Lifesciences to complement and cross-verify current analyst consensus on Edwards Lifesciences Corporation. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Edwards Lifesciences is not overpriced, please confirm all Edwards Lifesciences fundamentals including its EBITDA, Earnings Per Share, Z Score, as well as the relationship between Debt to Equity and Total Asset . Given that Edwards Lifesciences has Price to Earning of 34.46 times, we urge you verify Edwards Lifesciences Corporation market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.5Value At Risk2.21
Potential Upside3.05Standard Deviation1.51
 Return Density 

Edwards Lifesciences Greeks

Alpha over DOW
βBeta against DOW=1.36
Overall volatility
 IrInformation ratio =0.19

Edwards Lifesciences Volatility Alert

Edwards Lifesciences Corporation has relatively low volatility with skewness of 0.33 and kurtosis of 0.09. However, we advise all investors to independently investigate Edwards Lifesciences Corporation to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare Edwards Lifesciences to competition
FundamentalsEdwards LifesciencesPeer Average
Return On Equity25.45 % (15.17) %
Return On Asset12.64 % (15.64) %
Profit Margin22.47 % (5.5) %
Operating Margin29.97 % (10.91) %
Current Valuation24.61 B152.14 B
Shares Outstanding211.62 M1.43 B
Shares Owned by Insiders3.94 % 6.91 %
Number of Shares Shorted2.23 M3.24 M
Price to Earning34.46 times40.69 times
Price to Book7.91 times14.44 times
Price to Sales7.55 times17.81 times
Revenue3.31 B9.85 B
Gross Profit2.17 B21.75 B
EBITDA1.07 B1.41 B
Net Income744.9 M517.71 M
Cash and Equivalents1.4 B3.89 B
Cash per Share6.63 times5.17 times
Total Debt1.03 B7.36 B
Debt to Equity32.7 % 0.72 %
Current Ratio3.49 times3.3 times
Book Value Per Share14.95 times13.64 times
Cash Flow from Operations837.9 M1.25 B
Short Ratio1.23 times2.09 times
Earnings Per Share3.43 times2.3 times
Price to Earnings To Growth1.93 times1.22 times
Number of Employees9.8 K10.67 K
Market Capitalization25.01 B29.78 B
Total Asset4.06 B126.86 B
Retained Earnings3.91 B38.24 B
Working Capital1.57 B3.58 B
Current Asset2.05 B36.8 B
Current Liabilities476.2 M33.34 B
Strong Buy


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Edwards Lifesciences exotic insider transaction detected [view details]
Risk Adjusted Performance0.1699
Market Risk Adjusted Performance0.3699
Mean Deviation1.11
Semi Deviation0.5719
Downside Deviation1.27
Coefficient Of Variation303.34
Standard Deviation1.51
Information Ratio0.1928
Jensen Alpha0.2212
Total Risk Alpha(0.11)
Sortino Ratio0.2298
Treynor Ratio0.3599
Maximum Drawdown5.29
Value At Risk(2.21)
Potential Upside3.05
Downside Variance1.61
Semi Variance0.3271
Expected Short fall(1.36)

Current Valuation

Edwards Lifesciences Current Valuation Analysis
Edwards Lifesciences Corporation is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Healthcare Products industry is currently estimated at about 233.55 Billion. Edwards Lifesciences retains roughly 24.61 Billion in current valuation claiming about 11% of equities under Healthcare Products industry.